Jörg P Halter

23PUBLICATIONS
64CO-AUTHORS
Implementation science and evaluationPharmacogenomicsImmunology not elsewhere classifiedHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jul 01, 2026
Evaluation of a novel eHealth-facilitated, post HCT-integrated care model on implementation and rehospitalization: results from the Swiss SMILe hybrid-RCT.

|Jun 24, 2026
Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study.

|May 26, 2026
Low-positive CMV IgG serostatus before allogeneic hematopoietic cell transplantation is not associated with increased CMV reactivation risk.

|Mar 04, 2026
Frequent NPM1 mutation, monoblastic/monocytic origin and prognostic significance of organ and system involvement in myeloid sarcoma: a multicenter study.

Alex Jenei, Béla Kajtár, Tamás László

|Jan 14, 2025
Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis.

Silke Heidenreich, Katharina Egger-Heidrich, Jörg P Halter

|Aug 13, 2024
Influence of comorbidities on outcome in 1102 patients with an allogeneic hematopoietic stem cell transplantation.

Marie Janscak, Anne Stelmes, Jana van den Berg

Pageof 4

Frequent Collaborators

8 joint publications

Jakob R Passweg

6 joint publications

Michael Medinger

4 joint publications

Yves Chalandon

3 joint publications

Claire Seydoux